TRKs inhibitor therapy(KinaRx)

N/A

Report date: 2024/07/08 17:21:13
NME

Base Information

Drug NameTRKs inhibitor therapy(KinaRx)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTropomyosin-related kinase inhibitors
TargetsTropomyosin-related kinase
Therapy Area/IndicationsLung NeoplasmsHead and Neck NeoplasmsThyroid Neoplasms +[5] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesKinaRx Inc
China Registration ClassN/A

Develop Information

Active CompaniesKinaRx Inc
Inactive CompaniesN/A
Active IndicationsLung NeoplasmsHead and Neck NeoplasmsThyroid Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A